Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma. | Front Oncol | 2021 | 34307148 | PubTator, text mining | PubMed |
| Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target. | Cancers (Basel) | 2021 | 34298653 | PubTator, text mining | PubMed |
| The effects of genetic polymorphisms on benzene-exposed workers: A systematic review. | Health Sci Rep | 2021 | 34295994 | PubTator, text mining | PubMed |
| Morphologic and Molecular Findings in Myxoid Hepatic Adenomas. | Am J Surg Pathol | 2021 | 34232602 | PubTator, text mining | PubMed |
| Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy? | Cancers (Basel) | 2021 | 34208195 | PubTator, text mining | PubMed |
| Rad52 Oligomeric N-Terminal Domain Stabilizes Rad51 Nucleoprotein Filaments and Contributes to Their Protection against Srs2. | Cells | 2021 | 34207997 | PubTator, text mining | PubMed |
| Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival. | Cancers (Basel) | 2021 | 34207556 | PubTator, text mining | PubMed |
| Pterygium-The Good, the Bad, and the Ugly. | Cells | 2021 | 34206333 | PubTator, text mining | PubMed |
| Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families. | J Pers Med | 2021 | 34204722 | PubTator, text mining | PubMed |
| Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. | Pharmaceutics | 2021 | 34203761 | PubTator, text mining | PubMed |
| Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. | Int J Mol Sci | 2021 | 34200975 | PubTator, text mining | PubMed |
| RAD51D Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants. | Cancers (Basel) | 2021 | 34200360 | PubTator, text mining | PubMed |
| KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance. | Biol Open | 2021 | 34184733 | PubTator, text mining | PubMed |
| Rrp1 translocase and ubiquitin ligase activities restrict the genome destabilising effects of Rad51 in fission yeast. | Nucleic Acids Res | 2021 | 34157114 | PubTator, text mining | PubMed |
| Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer. | J Exp Clin Cancer Res | 2021 | 34154613 | PubTator, text mining | PubMed |
| Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma. | BMC Cancer | 2021 | 34140011 | PubTator, text mining | PubMed |
| Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden. | BMC Cancer | 2021 | 34130653 | PubTator, text mining | PubMed |
| GLI1: A Therapeutic Target for Cancer. | Front Oncol | 2021 | 34113570 | PubTator, text mining | PubMed |
| Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study. | Mol Biol Rep | 2021 | 34097201 | PubTator, text mining | PubMed |
| Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM). | Br J Cancer | 2021 | 34088988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=26